Key Market Indicators
The country ranked number 9 in 2021, Romania came ahead with $246,050,000. France, Italy and Germany respectively came in numbers 2, 3 and 4 in this ranking. Sales of diabetes medication in Hungary are set to reach $289 million by 2026, up from $253 million in 2021. This shows an average annual growth rate of 2.5%. Since 2008, the Hungarian market has grown by 9.5% each year. Hungary came in at 12th place in 2021, with Chile in the lead at $253 million. Canada, Spain and Italy followed in second, third and fourth place respectively. The export of insulin from Hungary is predicted to reach $93 million by 2026, up from $83 million in 2021. This shows an average growth rate of 2.1% per year. Since 2001, Hungarian supply has increased by 6.8% annually. Hungary was ranked seventh in 2021, with India at the top with $83 million. France, Italy and China came in second, third and fourth place respectively. The import of insulin into Hungary is expected to reach $290 million in 2026, up from $246 million in 2021. This corresponds to an average growth rate of 2.9% each year. Since 1997, Hungarian demand has increased by 10.8% annually. In 2021, Hungary was ninth in the ranking, with Romania in the lead at $246 million. France, Italy and Germany occupied second, third and fourth place respectively.
